Maternal Plasma Fibronectin and Advanced Oxidative Protein Products for the Prediction of Preeclampsia in High Risk Pregnancies: A Prospective Cohort Study

Publisher： Karger

E-ISSN： 1421-9964|26|4|189-194

ISSN： 1015-3837

Source： Fetal Diagnosis and Therapy, Vol.26, Iss.4, 2009-11, pp. : 189-194

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Total Fibronectin in Maternal Plasma as a Predictor for Preeclampsia

By  

Gynecologic and Obstetric Investigation, Vol. 47, Iss. 2, 1999-02 ,pp. : 89-94

Karger

Access to resources Recommend Favorite

Maternal Serum Placental Growth Factor, Pregnancy-Associated Plasma Protein-A and Free β-Human Chorionic Gonadotrophin at 30-33 Weeks in the Prediction of Pre-Eclampsia

By  

Fetal Diagnosis and Therapy, Vol. 33, Iss. 3, 2013-02 ,pp. : 164-172

Karger

Access to resources Recommend Favorite

Maternal Anxiety and the Second-Trimester Prenatal Screening: A Prospective Cohort Study

By  

Fetal Diagnosis and Therapy, Vol. 38, Iss. 4, 2015-0 ,pp. : 269-275

Karger

Access to resources Recommend Favorite

Accumulation of Advanced Glycation End Products Involved in Inflammation and Contributing to Severe Preeclampsia, in Maternal Blood, Umbilical Blood and Placental Tissues

By  

Gynecologic and Obstetric Investigation, Vol. 82, Iss. 4, 2016-08 ,pp. : 388-397

Karger

Access to resources Recommend Favorite

Maternal Plasma Nerve Growth Factor at the 11+0-13+6 Weeks' Scan as a Potential Angiogenic Marker of Preeclampsia: A Pilot Study

By  

Fetal Diagnosis and Therapy, Vol. 41, Iss. 3, 2016-08 ,pp. : 202-208

Karger

Access to resources Recommend Favorite